ENVASARC: A PIVOTAL TRIAL OF ENVAFOLIMAB, AND ENVAFOLIMAB IN COMBINATION WITH IPILIMUMAB, IN PATIENTS WITH ADVANCED OR METASTATIC UNDIFFERENTIATED PLEOMORPHIC SARCOMA OR MYXOFIBROSARCOMA WHO HAVE PROGRESSED ON PRIOR CHEMOTHERAPY
Clinical Trial Grant
Awarded By
Tracon Pharmaceuticals, Inc.
Start Date
October 23, 2020
End Date
August 11, 2025
Awarded By
Tracon Pharmaceuticals, Inc.
Start Date
October 23, 2020
End Date
August 11, 2025